Modulation of human mesenchymal stem cell function in a three-dimensional matrix promotes attenuation of adverse remodelling after myocardial infarction

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 3, 2013, Pages 192-202

  Simpson, David L ^a   Dudley, Samuel C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cell therapy; Mesenchymal stem cells; Myocardial infarction; Neovascularization; Paracrine effect; Tissue engineering

Indexed keywords

CARDIOLOGY; CELL ENGINEERING; COLLAGEN; DIRECT INJECTION; ENDOTHELIAL CELLS; HEART; MONOLAYERS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CELL DELIVERY; CELL THERAPY; HUMAN MESENCHYMAL STEM CELLS; LEFT VENTRICLES; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; NEO-VASCULARIZATION; PARACRINE; PARACRINE EFFECT; TISSUES ENGINEERINGS;

CELL CULTURE;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL;

EID: 84874730709     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.511     Document Type: Article

References (37)

1. Ahearne M, Wilson SL, Liu KK, et al. 2010; Influence of cell and collagen concentration on the cell-matrix mechanical relationship in a corneal stroma wound healing model. Exp Eye Res 91(5): 584-591.
2. Assmus B, Honold J, Schachinger V, et al. 2006; Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355(12): 1222-1232.
3. Bidarra SJ, Barrias CC, Barbosa MA, et al. 2010; Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. Biomacromolecules 11(8): 1956-1964.
4. Bosnakovski D, Mizuno M, Kim G, et al. 2006; Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng 93(6): 1152-1163.
5. Butcher JT, Barrett BC, Nerem RM. 2006; Equibiaxial strain stimulates fibroblastic phenotype shift in smooth muscle cells in an engineered tissue model of the aortic wall. Biomaterials 27(30): 5252-5258.
6. Chen L, Tredget EE, Wu PY, et al. 2008; Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3(4): e1886.
7. Cooperman L, Michaeli D. 1984; The immunogenicity of injectable collagen. I. A 1-year prospective study. J Am Acad Dermatol 10(4): 638-646.
8. Cummings CL, Gawlitta D, Nerem RM, et al. 2004; Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 25(17): 3699-3706.
9. Derval N, Barandon L, Dufourcq P, et al. 2008; Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur J Cardiothorac Surg 34(2): 248-254.
10. Donzelli E, Salvade A, Mimo P, et al. 2007; Mesenchymal stem cells cultured on a collagen scaffold: in vitro osteogenic differentiation. Arch Oral Biol 52(1): 64-73.
11. El Tamer MK, Reis RL. 2009; Progenitor and stem cells for bone and cartilage regeneration. J Tissue Eng Regen Med 3(5): 327-337.
12. Freyman T, Polin G, Osman H, et al. 2006; A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27(9): 1114-1122.
13. Gospodarowicz D, Ferrara N, Schweigerer L, et al. 1987; Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8(2): 95-114.
14. Gullberg DE, Lundgren-Akerlund E. 2002; Collagen-binding I domain integrins - what do they do? Prog Histochem Cytochem 37(1): 3-54.
15. Hatzistergos KE, Quevedo H, Oskouei BN, et al. 2010; Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107(7): 913-922.
16. Healy KE, Rezania A, Stile RA. 1999; Designing biomaterials to direct biological responses. Ann N Y Acad Sci 875: 24-35.
17. Hou D, Youssef EA, Brinton TJ, et al. 2005; Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112(Suppl 9): I150-156.
18. Hung SC, Pochampally RR, Chen SC, et al. 2007; Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25(9): 2363-2370.
19. Li JH, Zhang N, Wang JA. 2008; Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Invest 31(2): 103-110.
20. Lunde K, Solheim S, Aakhus S, et al. 2006; Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355(12): 1199-1209.
21. Miyagawa S, Sawa Y, Sakakida S, et al. 2005; Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 80(11): 1586-1595.
22. Mol A, Smits AI, Bouten CV, et al. 2009; Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 6(3): 259-275.
23. Potapova IA, Gaudette GR, Brink PR, et al. 2007; Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25(7): 1761-1768.
24. Samadikuchaksaraei A. 2007; An overview of tissue engineering approaches for management of spinal cord injuries. J Neuroeng Rehabil 4: 15.
25. Schachinger V, Assmus B, Britten MB, et al. 2004; Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44(8): 1690-1699.
26. Schuleri KH, Amado LC, Boyle AJ, et al. 2008; Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294(5): H2002-H2011.
27. Schuliga MJ, See I, Ong SC, et al. 2009; Fibrillar collagen clamps lung mesenchymal cells in a non-proliferative and non-contractile phenotype. Am J Respir Cell Mol Biol 41(6): 731-741.
28. Shin H. 2007; Fabrication methods of an engineered microenvironment for analysis of cell-biomaterial interactions. Biomaterials 28(2): 126-133.
29. Simpson D, Liu H, Fan TH, et al. 2007; A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25(9): 2350-2357.
30. Takagawa J, Zhang Y, Wong ML, et al. 2007; Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol 102(6): 2104-2111.
31. Tang YL, Zhao Q, Zhang YC, et al. 2004; Autologous mesenchymal stem cell transplantation induces VEGF and neovascularization in ischemic myocardium. Regul Pept 117(1): 3-10.
32. Wong HL, Wang MX, Cheung PT, et al. 2007; A 3D collagen microsphere culture system for GDNF-secreting HEK293 cells with enhanced protein productivity. Biomaterials 28(35): 5369-5380.
33. Xie TX, Xia Z, Zhang N, et al. 2010; Constitutive NF-κB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep 23(3): 725-732.
34. Xu J, Zutter MM, Santoro SA, et al. 1998; A three-dimensional collagen lattice activates NF-κB in human fibroblasts: role in integrin α2 gene expression and tissue remodeling. J Cell Biol 140(3): 709-719.
35. Zhang M, Mal N, Kiedrowski M, et al. 2007; SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21(12): 3197-3207.
36. Zhang WJ, Liu W, Cui L, et al. 2007; Tissue engineering of blood vessel. J Cell Mol Med 11(5): 945-957.
37. Zimmermann WH, Melnychenko I, Wasmeier G, et al. 2006; Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12(4): 452-458.